NETSPOT (gallium dotatate ga-68)
NETSPOT is a radioactive diagnostic tool used during PET imaging to help locate neuroendocrine tumors in both adult and pediatric patients. It helps clinicians identify specific malignant cells that express somatostatin receptors on their surface. This agent is used to visualize the presence and position of these tumors throughout the body.
How NETSPOT Works
This agent works by binding to somatostatin receptors, particularly subtype 2, which are often found in high concentrations on the surface of neuroendocrine tumor cells. Once attached, the gallium-68 isotope emits signals that are captured during a PET scan. This process allows for the precise localization of malignant cells that overexpress these specific receptors.
Details
- Status
- Prescription
- First Approved
- 2016-06-01
- Patent Cliff
- 2032
- Routes
- INTRAVENOUS
- Dosage Forms
- POWDER
NETSPOT Approval History
What NETSPOT Treats
1 indicationsNETSPOT is approved for 1 conditions since its original approval in 2016. These indications span multiple therapeutic areas including oncology, immunology, and more.
- Neuroendocrine Tumors
NETSPOT Competitive Set
ProThree rings of competition based on shared molecular targets and treated indications.
Direct competitors
Same target(s) AND same indication — head-to-head.
MoA expansion candidates
Same target(s), different indications — where else is this mechanism being explored?
Indication competitors
Same indication, different mechanism — what else might this patient receive?
Filters applied: drops same-active-ingredient (505(b)(2) reformulations), route-mismatch (topical vs systemic), and cross-therapeutic-area matches in same-indication rings.
Drugs Similar to NETSPOT
3 of 4FDA-approved drugs for similar conditions. Compare mechanisms and indications to understand treatment alternatives.
Active Pipeline
Ongoing clinical trials by development phase
Key Completed Trials
Completed studies with published results, ranked by significance
Trial Timeline
Full development history with FDA approval milestones
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
NETSPOT FDA Label Details
Indications & Usage
FDA Label (PDF)NETSPOT is indicated for the treatment of Neuroendocrine Tumors.
NETSPOT Patents & Exclusivity
Patents (1 active)
Pro Intelligence Preview
Deep insights for NETSPOT
Revenue Insights
- • Quarterly revenue tracking
- • Historical trend analysis
Patent Timeline
- • Cliff: 2032
- • 1 active patents
Trial Analysis
- • Clinical trial tracking
- • Development stage analysis
Competitive Landscape
- • 4 similar drugs
- • Same target/indication analysis
Full approval history • All patents • Revenue trends • Competitor analysis
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.